Amicus Brief Eli Lilly v Cochran Re 340B Contract Pharmacy – Intervention filed June 23, 2021.
340B Drug Pricing Program Legal Resources
Latest
Amicus Brief NOVO NORDISK v Cochran Re 340B Contract Pharmacy – Intervention
The 340B program, established by section 340B of the Public Health Service
Act, 42 U.S.C. § 256b, requires as a condition of participating in Medicaid and Medicare Part B that pharmaceutical manufacturers sell outpatient drugs at a discounted price to certain public and not-for-profit hospitals, community health centers, and other providers that serve patients with low incomes (340B providers or covered entities).
IN THE
Supreme Court of the United States
THE AMERICAN HOSPITAL ASSOCIATION, et al.,
Petitioners,
v.
American Hospital Association, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, National Association of Children’s Hospitals d/b/a Children’s Hospital Association, and American Society of Health-System Pharmacists, by and through their undersigned attorneys, hereby file this amicus brief in support of Defendants’ opposition to the motion for summary judgment filed by AstraZeneca Pharmaceuticals LP (AstraZeneca).
Motion and Memorandum in Support of Motion to Intervene NOVO NORDISK v Cochran (March 2, 2021)
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEW JERSEY
Government’s Opposition to Motion to Intervene - AstraZeneca v. Cochran (March 12, 2021)
AstraZeneca’s Opposition to Motion to Intervene (March 12, 2021) Insert
Associations’ Reply in Support of Motion to Intervene - AstraZeneca v. Cochran (March 19, 2021)
American Hospital Association, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, National Association of Children’s Hospitals d/b/a Children’s Hospital Association, and American Society of HealthSystem Pharmacists (collectively the “Proposed Intervenors”) move this Court, pursuant to Federal Rule of Civil Procedure 24(a) or in the alternative pursuant to Federal Rule of Civil Procedure 24(b), for an Order granting their Motion to Intervene in this lawsuit regarding the 340B Drug Discount Program.
Response to Motion to Intervene - SANOFI-AVENTIS vs HHS (March 22, 2021)
UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF INDIANA
INDIANAPOLIS DIVISION
IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF INDIANA
INDIANAPOLIS DIVISION
Amicus Brief–Hospital Systems - 340B Payment Reductions March 12 2021
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
ASTRAZENECA PHARMACEUTICALS LP
Amicus Brief-State and Regional Hosp Associations 340B Case
Memorandum in Support of Motion to Intervene regarding 340B Contract Pharmacy